Showing results (21-30 of 92) with videos related to

Sort By:
Pageof 10
The Journal of Community and Supportive Oncology|July 8, 2014
Practice challenges affecting optimal care as identifed by US medical oncologists who treat renal cell carcinomasSean M Hayes, Andrew D Bowser, Jim Mortimer, et al.
Cancer Research|February 10, 2011
Noncytotoxic differentiation treatment of renal cell cancerSoledad Negrotto, Zhenbo Hu, Oscar Alcazar, et al.
Annals of Surgery|June 17, 2020
A Modern Assessment of Cancer Risk in Adrenal Incidentalomas: Analysis of 2219 PatientsBora Kahramangil, Emin Kose, Erick M Remer, et al.
Genes, Chromosomes & Cancer|May 18, 2011
Germline and somatic DNA methylation and epigenetic regulation of KILLIN in renal cell carcinomaKristi L Bennett, Rebecca Campbell, Shireen Ganapathi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 2005
Successful implementation of the randomized discontinuation trial design: an application to the study of the putative antiangiogenic agent carboxyaminoimidazole in renal cell carcinoma--CALGB 69901Walter M Stadler, Gary Rosner, Eric Small, et al.
Bladder Cancer (Amsterdam, Netherlands)|February 3, 2017
Change in Psoas Muscle Volume as a Predictor of Outcomes in Patients Treated with Chemotherapy and Radical Cystectomy for Muscle-Invasive Bladder CancerHomayoun Zargar, Nima Almassi, Evan Kovac, et al.
Clinical Genitourinary Cancer|February 12, 2018
Drug Holiday in Metastatic Renal-Cell Carcinoma Patients Treated With Vascular Endothelial Growth Factor Receptor InhibitorsKriti Mittal, Lisa Derosa, Laurence Albiges, et al.
Pageof 10